13G Filing: Perceptive Advisors and Ocera Therapeutics Inc. (OCRX)

Page 7 of 8 – SEC Filing

CUSIP
No. 67552A108
13G Page
7 of 8 Pages
Item 8. Identification and
Classification of Members of the Group.
   
Not applicable.
   
Item 9. Notice of Dissolution of Group.
   
Not applicable.
Item 10. Certification.
     

The
following certification shall be included if the statement is filed pursuant to §240.13d-1(b)
with respect to Perceptive Advisors LLC:

   
  (a) By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are
held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as
a participant in any transaction having that purpose or effect. x
   

The
following certification shall be included if the statement is filed pursuant to §240.13d-1(c)
with respect to Joseph Edelman:

   
  (b) By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
x
   

The
following certification shall be included if the statement is filed pursuant to §240.13d-1(c)
with respect to Perceptive Life Sciences Master Fund Ltd:

   
  (c) By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
x

Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)